Dissertations: A survey of selected recent theses relevant to combating aging

Rejuvenation Research

Volumn 10, Issue 3, 2007, Pages 339-344

  De Grey, Aubrey D N J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-42]; BONE MORPHOGENETIC PROTEIN; BUNGAROTOXIN RECEPTOR; CALCIUM ION; CHOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIRCULAR DNA; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; FURA 2 ACETOXYMETHYL ESTER; GAMMA INTERFERON; HISTONE; HISTONE DEACETYLASE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METHYLLYCACONITINE; NERVE GROWTH FACTOR; NICOTINE; NICOTINIC RECEPTOR; NUCLEIC ACID; OLIGONUCLEOTIDE; PROTEIN P115; PROTEIN PMEL17; RETINOIC ACID; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BODY MOVEMENT; BRAIN DEVELOPMENT; BRAIN TISSUE; CARDIOVASCULAR EFFECT; CELL NUCLEUS TRANSPLANTATION; CELL PROTECTION; CHOLINERGIC NERVE CELL; CHROMOSOMAL INSTABILITY; CONCENTRATION RESPONSE; DEGENERATIVE DISEASE; DNA METHYLATION; DNA STRUCTURE; EMBRYO; EMBRYONIC STEM CELL; FIBROBLAST; GERONTOLOGICAL RESEARCH; HEART RATE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOTONEURON; MOTOR NEURON DISEASE; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; NUCLEIC ACID ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; REVIEW; SENILE PLAQUE; SPINAL CORD; STEM CELL TRANSPLANTATION; TELOMERE;

AGING; ALZHEIMER DISEASE; AMYLOID; ANIMALS; DISSERTATIONS, ACADEMIC; HUMANS; LONGEVITY; NEURONS; REJUVENATION; STEM CELLS; TELOMERE;

EID: 34548473081     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2007.0000     Document Type: Review

References (25)

1. Bertoni-Freddari C, Fattoretti P, Giorgetti B, Grossi Y, Balietti M, Casoli T, Di Stefano G, Perretta G. Synaptic pathology in the brain cortex of old monkeys as an early alteration in senile plaque formation. Rejuvenation Res 2006;9(1):85-88.
2. Flanary B. The role of microglial cellular senescence in the aging and Alzheimer diseased brain. Rejuvenation Res 2005;8(2):82-85.
3. Nixon RA. Autophagy in Alzheimer's disease pathogenesis. Rejuvenation Res 2005;8:S43.
4. Ingram VM, Blanchard BJ, Ahmad A, Zhang L, Rozeboom L. Alzheimer's, Huntington's and prion diseases - why are misfolded proteins so interesting, but so destructive? Rejuvenation Res 2005;8:S34.
5. Kaushal S. Manipulating the intracellular fate of an aggregate-prone protein. Rejuvenation Res 2005;8:S37.
6. Blasco MA. Telomeres and human disease: A matter of bad ends. Rejuvenation Res 2005;8:S23-S24.
7. Campisi J. Cellular senescence, cancer and aging. Rejuvenation Res 2005;8:S25.
8. Siddiqa A, Cavazos DA, Marciniak RA. Targeting telomerase. Rejuvenation Res 2006;9(3):378-390.
9. Blagoev KB, Goodwin EH. Computer simulation of telomere dynamics and senescence. Rejuvenation Res 2005;8:S23.
10. Pepys MB. Ageing, amyloid and amyloidosis: From pathogenesis to therapy. Rejuvenation Res 2005;8:S45.
11. Lemere CA, Maier M, Jiang L, Peng Y, Seabrook TJ. Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: Lessons from mice, monkeys, and humans. Rejuvenation Res 2006;9(1):77-84.
12. Rubinsztein DC. Macroautophagy upregulation - a candidate therapeutic strategy to enhance clearance of toxic intracellular aggregate-prone proteins. Rejuvenation Res 2005;8:S47.
13. Tuszynski MH, Conner JM, Ex vivo gene delivery of NGF in Alzheimer's disease. Rejuvenation Res 2005;8:S27.
14. Wilson SM, Patel J, Dealler S, Rosedale R, Stanley CJ. Tackling the diseases of old age; progress towards an Alzheimer's therapeutic. Rejuvenation Res 2005;8:S54.
15. Atala A. Tissue engineering, stem cells and cloning: Current concepts and changing trends. Rejuvenation Res 2005;8:S20-S21.
16. Esmaeili F, Tiraihi T, Movahedin M, Mowla SJ. Selegiline induces neuronal phenotype and neurotrophins expression in embryonic stem cells. Rejuvenation Res 2006;9(4):475-484.
17. West MD, Klimanskaya I, Lanza RP. Strategies for the reversal of the aging of human somatic cells. Rejuvenation Res 2005;8:S54.
18. de Grey ADNJ. Interspecies SCNT with ES cell mito-rescue: A proposed solution to some key ethical and logistical problems. Rejuvenation Res 2005;8:S29.
19. Rybouchkin A, Kato Y, Tsunoda Y. Enhanced reprogramming to facilitate production of somatic cell NT ES cell lines. Rejuvenation Res 2005;8:S47.
20. Holm TM, Jackson-Grusby L, Bambrick T, Yamada Y, Rideout WM, Jaenisch R. Global loss of imprinting in embryonic stem cells leads to widespread tumorigenesis in adult mice. Rejuvenation Res 2005;8:S33.
21. Han X, Berardi P, Riabowol K. Chromatin modification and senescence: Linkage by tumor suppressors? Rejuvenation Res 2006;9(1):69-76.
22. Maier AB, Westendorp RGJ, van Heemst D. Cellular ageing in fibroblast cultures from elderly aged 90 years old. Rejuvenation Res 2005;8:S52-S53.
23. Aiken JM, McKenzie D. The role of mtDNA deletion mutations in sarcopenia. Rejuvenation Res 2005;8:S19.
24. Conboy IM. Understanding and reversing aging of muscle precursor cells. Rejuvenation Res 2005;8:S27.
25. Pak JW, Aiken JM. Selective accumulation of mtDNA deletion mutations in aged skeletal muscle. Rejuvenation Res 2005;8:S43-S44.